🩺 Clinical Approach to Disorders of Puberty
🔹 Step 1: Define abnormal timing
• Precocious: breast development <8y (girls) or testicular enlargement <9y (boys).
• Delayed: no breast by 13y, no menarche by 16y (girls); no testicular enlargement by 14y (boys).
🔹 Step 2: Differentiate central vs peripheral precocious puberty
• Central (CPP): GnRH-dependent, progressive, symmetric, bone age advanced, LH-predominant response to GnRH stimulation.
• Peripheral (PPP): GnRH-independent, may be asymmetric, sex steroid elevated but low/normal LH. Causes: McCune-Albright (café-au-lait, polyostotic fibrous dysplasia), CAH (17-OHP elevated), testotoxicosis (boys), adrenal/ovarian tumor.
🔹 Step 3: Evaluate delayed puberty
• Bone age: delayed = constitutional delay vs hypogonadism.
• FSH/LH: low = hypogonadotropic; high = hypergonadotropic.
• Hypogonadotropic: constitutional delay (most common), chronic disease, Kallmann (anosmia), pituitary tumor, anorexia.
• Hypergonadotropic: Turner (girls), Klinefelter (boys), gonadal failure.
🔹 Step 4: Key diagnostic tests
• Bone age X-ray (left hand/wrist).
• GnRH stimulation test: peak LH >5-8 IU/L = central precocious puberty.
• Basal LH, FSH, estradiol/testosterone, DHEA-S, 17-OHP.
• Pelvic ultrasound (girls: ovarian/uterine size).
• Brain MRI (CPP in boys, rapid progression, age <6y, neurologic signs).
🔹 Step 5: Treatment overview
• CPP: GnRH agonists (leuprolide) slow progression, preserve adult height.
• PPP: treat underlying cause (surgery for tumor, hydrocortisone for CAH, aromatase inhibitors/testolactone).
• Constitutional delay: reassurance, observation; consider low-dose sex steroids if psychosocial distress.
• Hypogonadism: sex steroid replacement (estrogen/testosterone), treat underlying cause.